#Lung Fibroblast Derived Ipscs

[creativeera]

The Global Induced Pluripotent Stem Cells Market is Trending Towards Personalized Medicine

The global induced pluripotent stem cells market is witnessing trends towards personalized medicine as induced pluripotent stem cells provide a patient-specific approach to develop cell therapies. Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like state through the forced expression of transcription factors. These cells can be generated directly from adult tissues such as skin or blood and can proliferate indefinitely. Once reprogrammed, iPSCs can be differentiated into many other cell types such as nerve cells, heart cells, pancreatic cells and others. This unique capability offers enormous promise for regenerative medicine and disease modelling. The global induced pluripotent stem cells market was valued at US$ 1,595.4 Mn in 2023 and is expected to reach US$ 3,707 Mn by 2031, growing at a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031.  

iPSCs provide a potential alternative to human embryonic stem cells for disease modeling, drug discovery, and cell-based regenerative therapies. These cells circumvent controversies of using embryonic stem cells and the need for harvesting tissue-specific stem cells from adult tissues. This has led to an increase in research activities using iPSCs to model neurodegenerative diseases, cardiovascular diseases, and explore opportunities for cellular therapies. Key Takeaways Key players operating in the global induced pluripotent stem cells market are Takara Bio Inc., Thermo Fisher Scientific, Fujifilm Holdings Corporation, Astellas Pharma, Fate Therapeutics, Ncardia, ViaCyte, Cellular Dynamics International, Lonza, Blueprint Medicines and Other Prominent Players. These players are investing in developing new cell reprogramming and differentiation techniques which will enable mass production of iPSCs. The Global Induced Pluripotent Stem Cells Market Demand for induced pluripotent stem cells is growing due to increased investments in stem cell research and regenerative medicine. Many pharmaceutical companies are investing in developing personalized stem cell-based therapies and iPSC-derived disease models for drug discovery. Furthermore, increased awareness about potential applications of stem cell therapies is also boosting the demand. Key players are expanding globally to cater to the growing needs of research organizations and pharmaceutical companies. Companies are focusing on establishing facilities in Asia Pacific and Europe through partnerships and acquisitions. This is attributed to presence of considerable stem cell research bases and favorable regulations supporting research in these regions. Market Key Trends The Global Induced Pluripotent Stem Cells Market Size and Trends is witnessing trends towards three-dimensional (3D) culture techniques. 3D culture enables iPSC expansion as well as differentiation into various cell types in an environment that closely mimics in vivo conditions. Several companies are developing 3D bioprocessing platforms using hydrogels and biomaterials to facilitate mass production of iPSCs in a clinically relevant manner. This 3D culture technique is gaining popularity as it enhances stem cell growth, viability and differentiation potential. Porter's Analysis Threat of new entrants: New entrants face high initial costs of setting up research and production facilities for iPSCs. Bargaining power of buyers: Buyers have low bargaining power due to limited availability of substitutes and differentiated products offered by existing players. Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of alternative raw material sources and suppliers. Threat of new substitutes: Threat of substitutes is low as iPSCs offer significant advantages over other alternatives. Competitive rivalry: Market is consolidated with presence of few players conducting research on regenerative medicines using iPSCs. Geographical Regions North America accounts for the largest share of the global iPSCs market, primarily due to presence of major players and availability of research funding. Presence of advanced healthcare infrastructure and rising stem cell therapy adoption in the U.S. and Canada drives the regional market. Asia Pacific is poised to witness the fastest growth over the forecast period. Increasing initiative by governments in countries such as China, Japan, and India to develop domestic regenerative medicine industry presents lucrative growth opportunities. Additionally, lower labor and manufacturing costs attract companies to establish manufacturing facilities in Asia Pacific.

Get more insights on Global Induced Pluripotent Stem Cells Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[legendaryturtletheorist]

Exploring the Intricacies of Lung Cell Culture: A Gateway to Respiratory Research

Introduction

Lung cell culture is a vital tool in the field of respiratory research, offering a controlled environment for the growth and study of lung cells outside the human body. This technique has opened new frontiers in understanding the complexities of lung physiology, disease mechanisms, and drug development. In this article, we will explore the significance of lung cell culture, its applications, and the various methods used in its execution.

The Importance of Lung Cell Culture

Lung diseases, ranging from chronic obstructive pulmonary disease (COPD) to lung cancer and pulmonary fibrosis, exact a significant toll on human health worldwide. Research aimed at understanding the molecular and cellular underpinnings of these diseases is essential for developing effective treatments and therapies. Lung cell culture plays a pivotal role in this endeavor.

Disease Modeling and Mechanism Exploration

Lung cell culture allows researchers to create disease models in a controlled environment. By cultivating lung cells, scientists can expose them to specific environmental conditions, toxins, or pathogens to study how these factors influence cell behavior. This approach is invaluable for dissecting the molecular mechanisms behind lung diseases, including the development of abnormal cells, inflammation, and fibrosis.

Drug Development and Testing

Lung cell culture serves as a vital platform for drug development and testing. Pharmaceutical companies use cultured lung cells to screen potential drug candidates for their efficacy and safety. This method enables researchers to identify compounds that can effectively treat respiratory diseases and minimize side effects, ultimately leading to the development of better therapies.

Regenerative Medicine

Stem cell-based lung cell culture has immense potential for regenerative medicine. Researchers can cultivate patient-specific induced pluripotent stem cells (iPSCs) and differentiate them into lung cells. This technique offers a personalized approach to treatment, where damaged lung tissue can be replaced with healthy, patient-derived cells, minimizing the risk of rejection and improving long-term outcomes.

Types of Lung Cell Culture

Several methods are employed in lung cell culture, each tailored to specific research goals and applications. These methods include:

Primary Cell Culture

Primary lung cell culture involves isolating and culturing cells directly from lung tissue. This method provides a closer representation of in vivo conditions but has limitations in terms of cell longevity and reproducibility. Primary cell cultures are often used for short-term studies and experiments that require authentic cell behavior.

Established Cell Lines

Cell lines are immortalized cultures of lung cells that have been derived from human or animal sources. These lines have the advantage of being readily available and easily maintained, making them ideal for long-term experiments and high-throughput screening. Common lung cell lines include A549 (adenocarcinomic human alveolar basal epithelial cells) and BEAS-2B (immortalized human bronchial epithelial cells).

Stem Cell-Derived Lung Cells

Stem cell-based lung cell culture involves differentiating pluripotent stem cells, such as induced pluripotent stem cells (iPSCs), into lung-specific cell types. This method allows for the generation of various lung cell types, including alveolar epithelial cells, bronchial epithelial cells, and pulmonary fibroblasts, offering a versatile platform for disease modeling and regenerative medicine.

The Lung Cell Culture Process

The process of lung cell culture involves several key steps:

Cell Isolation

For primary cell culture, lung tissue is typically obtained from animal or human sources. The tissue is minced, enzymatically digested, and then the cells are isolated. For established cell lines, cells are maintained through regular subculturing.

Cell Seeding

Isolated lung cells or established cell lines are seeded onto culture dishes or plates. These dishes are coated with extracellular matrix proteins or other substrates to promote cell attachment and growth.

Growth Medium

Cells are incubated in a growth medium containing essential nutrients, growth factors, and antibiotics to promote cell survival and proliferation. The composition of the medium can vary depending on the specific cell type and research objectives.

Culture Conditions

Cells are cultured in a controlled environment with parameters such as temperature, humidity, and CO2 concentration closely regulated to mimic physiological conditions. This ensures optimal cell growth and behavior.

Applications of Lung Cell Culture

Lung cell culture has a wide range of applications in respiratory research:

Disease Modeling: Researchers use lung cell culture to recreate disease conditions, such as lung cancer or idiopathic pulmonary fibrosis, to study disease mechanisms and test potential treatments.

Drug Screening: Pharmaceutical companies employ lung cell culture to screen and evaluate drug candidates, leading to the development of new treatments for respiratory diseases.

Toxicology Studies: Cultured lung cells are used to assess the toxicity of environmental pollutants, drugs, and nanoparticles, helping to establish safety guidelines and regulations.

Regenerative Medicine: Stem cell-derived lung cells offer potential for personalized regenerative therapies, providing a means to replace damaged lung tissue.

Basic Research: Lung cell culture is instrumental in fundamental research to elucidate cellular and molecular processes in lung development, repair, and maintenance.

Challenges and Future Directions

While lung cell culture has revolutionized respiratory research, it is not without its challenges. Maintaining cell culture purity, ensuring the longevity of primary cells, and accurately recapitulating in vivo conditions are ongoing challenges.

Future directions in lung cell culture research include:

3D Culture Models: Developing three-dimensional (3D) culture systems that more closely mimic the in vivo lung microenvironment, including the use of organoids and lung-on-a-chip technology.

Co-Culture Systems: Incorporating multiple cell types, such as immune cells and endothelial cells, to create more complex and physiologically relevant models.

Single-Cell Analysis: Implementing single-cell RNA sequencing and proteomic techniques to gain deeper insights into cell heterogeneity and function within the lung.

Disease-Specific Models: Creating patient-derived lung cell cultures to better understand the genetic basis of lung diseases and test personalized treatment approaches.

Conclusion

Lung cell culture is an indispensable tool in respiratory research, offering a controlled and versatile platform for understanding lung physiology, modeling diseases, and developing therapeutic strategies. From primary cell culture to stem cell-derived models, researchers have an array of methods at their disposal to investigate the intricate workings of the lung. With ongoing advances in technology and methodology, the future of lung cell culture promises to yield even more insights into respiratory health and disease, ultimately benefiting patients and improving the treatment of lung disorders.

[cancersfakianakis1]

Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis

Lymphangioleiomyomatosis (LAM) is a progressive destructive neoplasm of the lung associated with inactivating mutations in the TSC1 or TSC2 tumor suppressor genes. Cell or animal models that accurately reflect the pathology of LAM have been challenging to develop. Here, we generated a robust human cell model of LAM by reprogramming TSC2 mutation–bearing fibroblasts from a patient with both tuberous sclerosis complex (TSC) and LAM (TSC-LAM) into induced pluripotent stem cells (iPSC), followed by selection of cells that resemble those found in LAM tumors by unbiased in vivo differentiation. We established expandable cell lines under smooth muscle cell (SMC) growth conditions that retained a patient-specific genomic TSC2+/− mutation and recapitulated the molecular and functional characteristics of pulmonary LAM cells. These include multiple indicators of hyperactive mTORC1 signaling, presence of specific neural crest and SMC markers, expression of VEGF-D and female sex hormone receptors, reduced autophagy, and metabolic reprogramming. Intriguingly, the LAM-like features of these cells suggest that haploinsufficiency at the TSC2 locus contributes to LAM pathology, and demonstrated that iPSC reprogramming and SMC lineage differentiation of somatic patient cells with germline mutations was a viable approach to generate LAM-like cells. The patient-derived SMC lines we have developed thus represent a novel cellular model of LAM that can advance our understanding of disease pathogenesis and develop therapeutic strategies against LAM. Cancer Res; 77(20); 5491–502. ©2017 AACR. http://ift.tt/2yrgcDk

[cancersfakianakis1]

Human pluripotent stem cell-derived TSC2-haploinsufficient smooth muscle cells recapitulate features of Lymphangioleiomyomatosis

Lymphangioleiomyomatosis (LAM) is a progressive destructive neoplasm of the lung associated with inactivating mutations in the TSC1 or TSC2 tumor suppressor genes. Cell or animal models that accurately reflect the pathology of LAM have been challenging to develop. Here we generated a robust human cell model of LAM by reprogramming TSC2 mutation-bearing fibroblasts from a patient with both Tuberous Sclerosis Complex (TSC) and LAM (TSC-LAM) into induced pluripotent stem cells (iPSCs), followed by selection of cells that resemble those found in LAM tumors by unbiased in vivo differentiation. We established expandable cell lines under smooth muscle cell (SMC) growth conditions that retained a patient-specific genomic TSC2+/- mutation and recapitulated the molecular and functional characteristics of pulmonary LAM cells. These include multiple indicators of hyperactive mTORC1 signaling, presence of specific neural crest and SMC markers, expression of VEGF-D and female sex hormone receptors, reduced autophagy, and metabolic reprogramming. Intriguingly, the LAM-like features of these cells suggest that haploinsufficiency at the TSC2 locus contributed to LAM pathology, and demonstrated that iPSC reprogramming and SMC lineage differentiation of somatic patient cells with germline mutations was a viable approach to generate LAM-like cells. The patient-derived SMC lines we have developed thus represent a novel cellular model of LAM which can advance our understanding of disease pathogenesis and develop therapeutic strategies against LAM. http://ift.tt/2wCBYTO